Drug
Taxane clinical trials
- studies test it
- 11
- open now
- 3
- in phase 3
- 3
- first study started
- 2002
Keep track of what changes. Save the taxane studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2015 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 5
- Phase 3
- 3
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 5
Bristol-Myers Squibb (3) · Hoffmann-La Roche (1) · Bayer (1) · New Mexico Cancer Research Alliance (1) · Fudan University (1) · ABL Bio, Inc. (1) · Sun Yat-sen University (1) · German Breast Group (1)
Often tested with
Tested in the same studies.
Paclitaxel (1) · Docetaxel (1) · Bevacizumab (1) · Capecitabine (1) · Carboplatin (1)
Studies
Open first, then newest update. How each study uses taxane is read from its arms, and is right about nine times in ten.
Testing it · 11
- Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast CancerNot yet recruitingPhase 2Fudan UniversityNCT07716046Written as Taxane
- ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid TumorsRecruitingPhase 1/2ABL Bio, Inc.NCT07158918Written as Taxane
- Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)RecruitingNot applicableSun Yat-sen UniversityNCT02624531Written as Taxane
- Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)Status unknownPhase 3Yonsei UniversityNCT02441933Written as taxane plus carboplatin
- A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast CancerCompletedPhase 2Hoffmann-La RocheNCT00475670Written as Taxane (docetaxel or paclitaxel)
- Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's LymphomaCompletedPhase 2BayerNCT00044551Written as Taxane (Cytotoxic, BAY59-8862)
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedPhase 3German Breast GroupNCT01200212Written as Taxane, Avastin
- A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With TaxanesCompletedPhase 3New Mexico Cancer Research AllianceNCT00277043Written as paclitaxel, docetaxel, taxane
- Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung CancerCompletedPhase 1/2Bristol-Myers SquibbNCT00103831Written as Oral Taxane
- A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced CancerTerminatedPhase 1Bristol-Myers SquibbNCT00326131Written as Oral Taxane
- A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced CancerTerminatedPhase 1Bristol-Myers SquibbNCT00332748Written as Oral Taxane
Given in every arm · 7 — taxane is usual care beside what is tested
- Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at DiagnosisRecruitingPhase 3SWOG Cancer Research NetworkNCT07578116Written as Taxane Compound
- Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast CancerRecruitingPhase 2Fudan UniversityNCT06355037Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast CancerNot yet recruitingPhase 4Shanghai Jiao Tong University School of MedicineNCT05843292Written as Taxane and Carboplatin
- Inosine Reverse Chemo Resistance in Triple Negative Breast CancerCompletedPhase 2Fudan UniversityNCT06355024Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First RelapseTerminatedPhase 3MorphotekNCT00849667Written as Taxane
- Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast CancerWithdrawnPhase 2/3Peregrine PharmaceuticalsNCT02651610Written as Taxane
- A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast CancerWithdrawnPhase 2Peregrine PharmaceuticalsNCT02685306Written as Taxane
As the comparator · 7 — what is tested is compared with taxane
- Organoid-based Functional Precision Therapy for Advanced Breast CancerRecruitingPhase 2Guangdong Provincial People's HospitalNCT06102824Written as Taxane
- Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)Active, not recruitingPhase 3AstraZenecaNCT04784715Written as Taxane
- Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer PatientsActive, not recruitingPhase 2Spanish Breast Cancer Research GroupNCT04293393Written as Taxane
- RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)CompletedPhase 2EpicentRx, Inc.NCT02489903Written as Taxane
- Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineCompletedNot applicableMasonic Cancer Center, University of MinnesotaNCT00293293Written as Standard chemotherapy
- A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerTerminatedPhase 2/3Hoffmann-La RocheNCT01641939Written as Taxane
- First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerCompletedPhase 2Shanghai Gynecologic Oncology GroupNCT01669226Written as TCiv
Codes
What other systems call taxane · ClinicalTrials.gg INT003721
- MeSH (NLM) C080625taxaneOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C080625 | taxane | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.